Risk for Immune-Mediated Graft Dysfunction in Liver Transplant Recipients With Recurrent HCV Infection Treated With Pegylated Interferon
2012 ◽
Vol 142
(5)
◽
pp. 1132-1139.e1
◽
2018 ◽
Vol 18
(10)
◽
pp. 2506-2512
◽
2017 ◽
Vol 45
(11)
◽
pp. 1427-1432
◽
2011 ◽
Vol 55
(1)
◽
pp. 207-217
◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 107
◽
pp. S150
Keyword(s):
2003 ◽
Vol 35
(4)
◽
pp. 1478-1479
◽